COVIVAXX Trademark

Trademark Overview

On Friday, November 20, 2020, a trademark application was filed for COVIVAXX with the United States Patent and Trademark Office. The USPTO has given the COVIVAXX trademark a serial number of 79309315. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 1, 2021. This trademark is owned by SERUM INSTITUTE OF INDIA PRIVATE LIMITED. The COVIVAXX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccine for human use
covivaxx

General Information

Serial Number79309315
Word MarkCOVIVAXX
Filing DateFriday, November 20, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaccine for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSERUM INSTITUTE OF INDIA PRIVATE LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events

Event DateEvent Description
Wednesday, December 21, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 1, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 1, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, October 17, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, September 28, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 28, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, December 1, 2021ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 1, 2021ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 1, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 31, 2021REFUSAL PROCESSED BY IB
Wednesday, May 12, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 12, 2021REFUSAL PROCESSED BY MPU
Sunday, May 9, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, May 8, 2021NON-FINAL ACTION WRITTEN
Friday, May 7, 2021ASSIGNED TO EXAMINER
Thursday, May 6, 2021ASSIGNED TO EXAMINER
Wednesday, May 5, 2021ASSIGNED TO EXAMINER
Tuesday, April 27, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 22, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

covivaxx human vaccine